# Efficacy and Safety Evaluation of PD1-BCMA-CART

> **NCT05308875** · NA · UNKNOWN · sponsor: **Bioray Laboratories** · enrollment: 9 (estimated)

## Conditions studied

- Multiple Myeloma

## Interventions

- **BIOLOGICAL:** PD1-BCMA-CART

## Key facts

- **NCT ID:** NCT05308875
- **Lead sponsor:** Bioray Laboratories
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-03-01
- **Primary completion:** 2025-01-01
- **Final completion:** 2025-10-01
- **Target enrollment:** 9 (ESTIMATED)
- **Last updated:** 2024-01-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05308875

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05308875, "Efficacy and Safety Evaluation of PD1-BCMA-CART". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT05308875. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*